Novavax, Inc. (NASDAQ:NVAX) concluded the trading at $4.67 on Wednesday, May 01, with a rise of 7.85% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $4.33 and 5Y monthly beta was reading 1.60. Considering stock’s 52-week price range provides that NVAX hit a high price of $11.36 and saw its price falling to a low level of $3.53 during that period. Over a period of past 1-month, stock came adding 3.09% in its value.
In contrast, when we review NVAX stock’s current outlook then short term indicators are assigning it an average of 50% Sell, while medium term indicators are categorizing the stock at an average of 50% Sell. Long term indicators are suggesting an average of 50% Sell for it.
Digging deeper we become aware of the PEG ratio of the NVAX stock which is currently positioned at 0. It further provides that stock’s current price level is 11.16% away from its 20-day simple moving average and is -0.49% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 59.54 while volatility remained at 6.73% over the past week which changes to 5.34% when measuring it over the past month. Beta is valued at 1.43, while measure of average true range or ATR is currently at 0.26.
Having a second look at Novavax, Inc. (NASDAQ:NVAX) provides that stock’s average daily trading volume for 3 months was 7.05 million. Number of outstanding shares of the stock stood at 139.51 million.
The percentage of outstanding shares held by the insiders is 4.98% while it is 57.10% for the institutional holders. Subtraction of -2.71% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
